Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.diagmicrobio.2020.115161 http://scihub22266oqcxt.onion/10.1016/j.diagmicrobio.2020.115161 32947206!7395943!32947206     free     free     free Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Diagn+Microbiol+Infect+Dis 2020 ; 98 (3): 115161 Nephropedia Template TP {{tp|p=32947206|t=2020. Retrospective clinical evaluation of 4 lateral flow assays for the detection of SARS-CoV-2 IgG |pdf=|usr=}}{{32947206}} gab.com Text Retrospective clinical evaluation of 4 lateral flow assays for the detection of SARS-CoV-2 IgG JO: Diagn Microbiol Infect Dis http://www.kidney.de/pget.php?&tw=1&pmid=32947206 #FOAvip In a Clinical Laboratory Improvement Amendments laboratory setting, we evaluated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) IgG detection with 4 lateral flow immunoassays [LFIAs; 2 iterations from BTNX Inc. (n?=?457) and 1 each from ACON Laboratories (n?=?200) and SD BIOSENSOR (n?=?155)]. In a cohort of primarily hospitalized, reverse-transcription polymerase chain reaction-confirmed coronavirus disease 2019 cases, sensitivity at >/=14?days from symptom onset was: BTNX kit 1, 95%; BTNX kit 2, 91%; ACON, 95%; and SD, 92%. All assays showed good concordance with the Abbott SARS-CoV-2 IgG assay at >/=14?days from symptom onset: BTNX kit 1, 99%; BTNX kit 2, 94%; ACON, 99%; and SD, 100%. Specificity, measured using specimens collected prior to SARS-CoV-2 circulation in the United States and "cross-reactivity challenge" specimens, was 98% for BTNX kit 1 and ACON and 100% for BTNX kit 2 and SD. These results suggest that LFIAs may provide adequate results for rapid detection of SARS-CoV-2. Twit Text FOAVip Retrospective clinical evaluation of 4 lateral flow assays for the detection of SARS-CoV-2 IgG ????Diagn Microbiol Infect Dis http://www.kidney.de/pget.php?&tw=1&pmid=32947206 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32947206 #FOAvip English Wikipedia <ref>{{Cite pmid|32947206}}</ref> Retrospective clinical evaluation of 4 lateral flow assays for the detection of SARS-CoV-2 IgG #MMPMID32947206 McAulay K; Bryan A; Greninger AL; Grill F; Lake D; Kaleta EJ; Grys TE Diagn Microbiol Infect Dis 2020[Nov]; 98 (3): 115161 PMID32947206show ga In a Clinical Laboratory Improvement Amendments laboratory setting, we evaluated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) IgG detection with 4 lateral flow immunoassays [LFIAs; 2 iterations from BTNX Inc. (n?=?457) and 1 each from ACON Laboratories (n?=?200) and SD BIOSENSOR (n?=?155)]. In a cohort of primarily hospitalized, reverse-transcription polymerase chain reaction-confirmed coronavirus disease 2019 cases, sensitivity at >/=14?days from symptom onset was: BTNX kit 1, 95%; BTNX kit 2, 91%; ACON, 95%; and SD, 92%. All assays showed good concordance with the Abbott SARS-CoV-2 IgG assay at >/=14?days from symptom onset: BTNX kit 1, 99%; BTNX kit 2, 94%; ACON, 99%; and SD, 100%. Specificity, measured using specimens collected prior to SARS-CoV-2 circulation in the United States and "cross-reactivity challenge" specimens, was 98% for BTNX kit 1 and ACON and 100% for BTNX kit 2 and SD. These results suggest that LFIAs may provide adequate results for rapid detection of SARS-CoV-2. |Antibodies, Viral/*blood[MESH] |Betacoronavirus/*immunology[MESH] |COVID-19[MESH] |Coronavirus Infections/*diagnosis[MESH] |Humans[MESH] |Immunoassay/*methods[MESH] |Immunoglobulin G/*blood[MESH] |Pandemics[MESH] |Pneumonia, Viral/*diagnosis[MESH] |Retrospective Studies[MESH] |Reverse Transcriptase Polymerase Chain Reaction/methods[MESH] |SARS-CoV-2[MESH]Retrospective clinical evaluation of 4 lateral flow assays for the det(epmc).pdf DeepDyve Pubget Overpricing